NCT05805501 2026-02-12
A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma
Hoffmann-La Roche
Phase 2 Active not recruiting
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Centre Georges Francois Leclerc